Aisling Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 8

Professionals

  • Investments
  • 245

  • Portfolio
  • 8

  • Exits
  • 169

Exits

Aisling Capital General Information

Company Description

Founded in 2000, Aisling Capital is a venture capital firm based in New York. The firm seeks to invest in healthcare and life science sectors based in Canada, Europe & American regions. This firm is a Registered Investment Adviser (RIA).

Business Details

Formerly Known As
Perseus Soros Management
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Corporate Office
  • 489 Fifth Avenue
  • Floor 10
  • New York, NY 10017
  • United States
+1 (212)

Aisling Capital Investments & Acquisitions (245)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Dren Bio 29-Oct-2026 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Claris Bio 24-Jul-2026 Biotechnology Clinical Trials - General
Allotera Therapeutics 08-Jul-2026 Drug Discovery Clinical Trials - Phase 2
Treeline Biosciences Holdings 01-Sep-2025 Drug Discovery Clinical Trials - Phase 1
Marker Therapeutics 19-Dec-2024 Biotechnology Generating Revenue
GondolaBio 16-Aug-2024 Drug Discovery Clinical Trials - Phase 2
BridgeBio Oncology Therapeutics 30-Apr-2024 Drug Discovery Clinical Trials - Phase 1
Mindful Health Solutions 01-Jan-2024 Clinics/Outpatient Services Generating Revenue
Bicara Therapeutics 06-Dec-2023 Later Stage VC Drug Discovery Generating Revenue
COMPASS Pathways 18-Aug-2023 PIPE Biotechnology Generating Revenue
You’re viewing 10 of 245 investments and acquisitions. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aisling Capital Exits (169)

Company Name Exit Date Exit Type Exit Size
Mindful Health Solutions 01-Jun-2026 Merger/Acquisition
COMPASS Pathways 20-Feb-2026
BridgeBio Oncology Therapeutics 11-Aug-2025
Stratus Therapeutics 04-Mar-2025
Poseida Therapeutics 08-Jan-2025
Prolacta Bioscience 30-Dec-2024
HerbalScience Group 02-Nov-2024
OnKure Therapeutics 04-Oct-2024
Reneo Pharmaceuticals 04-Oct-2024 Merger/Acquisition
Bicara Therapeutics 13-Sep-2024 IPO
You’re viewing 10 of 169 exits. Get the full list »

Aisling Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Aisling Capital‘s full profile, request access.

Request a free trial

Aisling Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Aisling Capital FAQs

  • What is Aisling Capital?

    Founded in 2000, Aisling Capital is a venture capital firm based in New York.

  • When was Aisling Capital founded?

    Aisling Capital was founded in 2000.

  • Where is Aisling Capital headquartered?

    Aisling Capital is headquartered in New York, NY.

  • What is Aisling Capital's total asset value?

    Aisling Capital has around in total assets under management.

  • How many investments has Aisling Capital made?

    Aisling Capital has made 245 investments.

  • What has Aisling Capital invested in?

    Aisling Capital has made numerous investments in companies like Dren Bio, Claris Bio, and Allotera Therapeutics within the Drug Discovery and Biotechnology industries.

  • What has Aisling Capital invested in recently?

    Aisling Capital's latest investment was on 29-Oct-2026 in Dren Bio, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process